Yu-Min Ko Selected Research

Yu-Min Ko Research Topics

10	Chronic Hepatitis C 01/2022 - 07/2016
8	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 07/2016
8	Infections 01/2022 - 06/2017
6	Fibrosis (Cirrhosis) 01/2023 - 10/2011
3	Neoplasms (Cancer) 01/2022 - 10/2011
3	Chronic Hepatitis B 01/2021 - 11/2020
3	Viremia 01/2021 - 01/2021
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 05/2017
2	Hepatitis B 01/2021 - 10/2017
2	Hepatitis C 01/2018 - 06/2017
2	Liver Diseases (Liver Disease) 05/2017 - 07/2016
1	Hyperlipidemias (Hyperlipidemia) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Hepatitis D 01/2021
1	Diabetes Mellitus 07/2016
1	Diabetic Nephropathies (Diabetic Nephropathy) 07/2013
1	Hypertrophy 07/2013
1	Breast Neoplasms (Breast Cancer) 10/2011
1	Ischemia 10/2011

8	Antiviral Agents (Antivirals)IBA 01/2023 - 07/2016
6	RNA (Ribonucleic Acid)IBA 01/2022 - 06/2017
4	Ribavirin (Virazole)FDA LinkGeneric 01/2022 - 06/2017
3	NucleosidesIBA 01/2021 - 11/2020
3	NucleotidesIBA 01/2021 - 11/2020
2	InterferonsIBA 01/2022 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 10/2017
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2021 - 10/2017
2	nasIBA 01/2021 - 01/2021
2	micaIBA 05/2017 - 01/2017
2	Glucose (Dextrose)FDA LinkGeneric 07/2016 - 07/2013
2	Transforming Growth Factors (Transforming Growth Factor)IBA 07/2013 - 10/2011
2	Proteins (Proteins, Gene)FDA Link 07/2013 - 10/2011
1	ChemokinesIBA 01/2022
1	CytokinesIBA 01/2022
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	lenvatinibIBA 01/2022
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	regorafenibIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	asunaprevirIBA 01/2020
1	daclatasvirIBA 01/2020
1	Vitamin D FDA LinkGeneric 12/2017
1	Peptides (Polypeptides)IBA 05/2017
1	Small Interfering RNA (siRNA)IBA 07/2013
1	Ubiquitin CIBA 07/2013
1	Fibronectins (Fibronectin)IBA 07/2013
1	Cyclin D1IBA 10/2011
1	annonacinIBA 10/2011
1	Estrogen ReceptorsIBA 10/2011
1	Tamoxifen FDA LinkGeneric 10/2011
1	Gefitinib (Iressa)FDA Link 10/2011
1	Phosphotransferases (Kinase)IBA 10/2011
1	ErbB Receptors (EGF Receptor)IBA 10/2011

10	Therapeutics 01/2023 - 07/2016
1	Salvage Therapy 01/2022